NO20062369L - Anvendelse av et pyrazoldedvat for fiemstilling av medikamenter for a hindre og behandle dyslipideml og sykdommer assosiert med dyslipidemi og/eller fedme - Google Patents
Anvendelse av et pyrazoldedvat for fiemstilling av medikamenter for a hindre og behandle dyslipideml og sykdommer assosiert med dyslipidemi og/eller fedmeInfo
- Publication number
- NO20062369L NO20062369L NO20062369A NO20062369A NO20062369L NO 20062369 L NO20062369 L NO 20062369L NO 20062369 A NO20062369 A NO 20062369A NO 20062369 A NO20062369 A NO 20062369A NO 20062369 L NO20062369 L NO 20062369L
- Authority
- NO
- Norway
- Prior art keywords
- dyslipidemia
- obesity
- manufacture
- medications
- diseases associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0312553A FR2861300B1 (fr) | 2003-10-24 | 2003-10-24 | Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique |
PCT/FR2004/002715 WO2005046689A2 (fr) | 2003-10-24 | 2004-10-22 | Utilisation d’un derive du pyrazole pour la prevention et le traitement des dyslipidemies et des maladies associees aux dyslipidemies et/ou a l’obesite |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062369L true NO20062369L (no) | 2006-05-24 |
Family
ID=34400824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062369A NO20062369L (no) | 2003-10-24 | 2006-05-24 | Anvendelse av et pyrazoldedvat for fiemstilling av medikamenter for a hindre og behandle dyslipideml og sykdommer assosiert med dyslipidemi og/eller fedme |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1893946A (xx) |
FR (1) | FR2861300B1 (xx) |
NO (1) | NO20062369L (xx) |
ZA (1) | ZA200604178B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102416015B (zh) * | 2011-08-23 | 2013-02-27 | 南京正宽医药科技有限公司 | 一种含他汀类药物的组合物及其用途 |
CN110237070A (zh) * | 2019-05-10 | 2019-09-17 | 辽宁大学 | 厄贝沙坦在制备降血脂药物中的应用 |
CN112007156A (zh) * | 2019-05-30 | 2020-12-01 | 复旦大学 | 大麻素受体药物在制备治疗心肌细胞坏死性凋亡药剂中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2758723B1 (fr) * | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
SI1429761T1 (sl) * | 2001-09-21 | 2007-02-28 | Solvay Pharm Bv | Novi 4,5-dihidro-1h-pirazolni derivati s cb1-antagonisticno aktivnostjo |
ATE486842T1 (de) * | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
US20050154202A1 (en) * | 2002-04-05 | 2005-07-14 | Hagmann William K. | Substituted aryl amides |
ES2380319T3 (es) * | 2002-07-09 | 2012-05-10 | Bristol-Myers Squibb Company | Derivados heterocíclicos sustituidos útiles como agentes antidiabéticos y anti-obesidad y procedimiento |
US6869966B2 (en) * | 2002-09-30 | 2005-03-22 | Banyu Pharmaceutical Co., Ltd. | N-substituted-2-oxodihydropyridine derivatives |
-
2003
- 2003-10-24 FR FR0312553A patent/FR2861300B1/fr not_active Expired - Fee Related
-
2004
- 2004-10-22 ZA ZA200604178A patent/ZA200604178B/xx unknown
- 2004-10-22 CN CNA2004800347327A patent/CN1893946A/zh active Pending
-
2006
- 2006-05-24 NO NO20062369A patent/NO20062369L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200604178B (en) | 2008-07-30 |
FR2861300B1 (fr) | 2008-07-11 |
CN1893946A (zh) | 2007-01-10 |
FR2861300A1 (fr) | 2005-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008076754A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
AR063550A2 (es) | Utilizacion de un derivado de pirazol para la preparcion de medicamentos utiles para la prevencion y eltratamiento de la displidemias y de las enefermedades asociadas a las dislipidemias y/o a la obesidad | |
WO2006047516A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
NO20083562L (no) | Cannabinoidreseptormodulatorer | |
WO2005000820A3 (fr) | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1 | |
WO2008043544A8 (en) | Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
MX2010001236A (es) | Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1). | |
WO2008040361A3 (en) | Use of a combination of hypothermia inducing drugs | |
WO2007009724A3 (en) | Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
TW200631945A (en) | The aromatic amide derivatives, the pharmaceutical composition comprising the same and its medical application | |
NO20075920L (no) | Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria | |
WO2009124552A3 (en) | Use of a combination of hypothermia inducing drugs | |
WO2008116663A3 (en) | Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments | |
NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
NO20062369L (no) | Anvendelse av et pyrazoldedvat for fiemstilling av medikamenter for a hindre og behandle dyslipideml og sykdommer assosiert med dyslipidemi og/eller fedme | |
WO2009071096A3 (en) | Combination of medical and physical cooling treatment of ischemic effects | |
MX2009008176A (es) | Derivados de tetrahidro-naftaleno sustituidos con heterociclos, su preparacion y su uso como medicamentos. | |
TW200626167A (en) | Sophorae Radix extract for prevention and treatment of respiratory diseases | |
NO20074768L (no) | Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer | |
WO2008111296A1 (ja) | 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬 | |
NO20080066L (no) | Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold | |
Fionda et al. | 42. The effects of THC on cutaneous silent period |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |